Rpf蛋白结构域的生物学及免疫学特性的初步研究
[Abstract]:Tuberculosis (TB) is a chronic infectious disease mainly caused by Mycobacterium tuberculosis (MTB). It is also one of the most important pathogenic and fatal factors in the world today. According to WHO, approximately 1/3 population in the world is in the state of MTB infection, and the number of TB patients in China is living in the world. The number of second people has reached 400 million. Only 10% of these people may eventually develop into active TB, and the overwhelming majority of them are recessive. The infected bacteria exist in the form of dormant bacteria. The drug resistance of this kind of dormant bacteria is very strong, it can exist in the body for a long time, and the conventional method is difficult to separate and culture. Bacille Calmette-Guerin (BCG) is M The TB strain is the only vaccine used for the prevention of TB, but it is ineffective for the recessive infection, and has the defects of short protection period and weak immune response. Therefore, the study of the pathogenesis and immune mechanism of MTB, the development of the more effective diagnosis, the treatment and prevention of MTB infection, especially the new methods, new measures and new vaccines against the recessive infection Significance.
In recent years, it is found that in the recovery process of MTB dormant bacteria, 5 kinds of Resuscitation promoting factor (Rpf) secreted by MTB have played an important role, which are Rv0867c (RpfA), Rv1009 (RpfB), Rv1884c (RpfC). Homology analysis found that Rpf exists in a variety of Gram-positive bacteria rich in G+C, and their gene encoded proteins have Rpf like domains. In the study, the domain of Rpf protein has a consistent biological characteristic with the complete Rpf protein. The study of the Rpf family also found that the Rpf like protein is not only related to the proliferation of bacteria, but also may be The target antigen identified by the host immune system.
In this study, we cloned, expressed and purified Rpf protein, Rpf domain protein and RpfB domain protein, respectively, and prepared a monoclonal antibody (monoclonal antibody, MAb) against the Rpf domain and anti RpfB domain of Micrococcus gonorrhoeae, and studied the biological function of Rpf, Rpf domain and RpfB domain protein of rattan Micrococcus. And immunological characteristics. Evaluate its application for MTB isolation and culture additives, the establishment of related antigen detection methods and the possibility of developing new TB vaccines. Objective: to express and purify Rpf, Rpf domain and RpfB domain protein of Micrococcus lutea, to prepare Rpf domain of Micrococcus Garcinia and to resist MAb in RpfB domain by the expression system of Escherichia coli. Further study of its biological and immunological characteristics.
Experimental methods and results:
1. clones of Rpf, Rpf domain and RpfB domain of Micrococcus luptois, expression and purification were amplified by PCR method from the genome of gonorrhoeae micrococcus and MTB H37Rv respectively, which were respectively amplified from Rpf, Rpf domain and RpfB domain target gene fragment respectively, and were cloned into pUC-19 vector and sequenced respectively, and the results were reported to GenBank reports. The target genes were cloned in human pProEX HTb expression vector respectively. After the enzyme digestion was identified, the target protein was induced by IPTG to express the target protein in E.coli. The 3 target proteins expressed by SDS-PAGE were in accordance with the expected molecular weight. The Western-blot analysis showed that the 3 fusion 6 * His target proteins could react with the anti 6 x His MAb specific.3. The target proteins were expressed in inclusion bodies, and 3 target proteins were purified by affinity chromatography under the condition of denaturation.
2. biological functions of Rpf, Rpf domain and RpfB domain of Micrococcus lutea
2.1 preparation and identification of RpfB domain MAb against Rpf domain of Micrococcus lutea
BALB/c mice were immunized with Rpf domain protein of Micrococcus Garcinia Micrococcus, and 3 hybridoma cell lines, which could secrete the Rpf domain MAb of anti Micrococcus, were obtained, named F3D10, G10D5, G6C8 respectively. F3D10, G10D5 were IgG1 subclasses and G6C8 were IgM subclasses. In white immunized BALB/c mice, 3 hybridoma cell lines, named D3A5, B8G11, A9C8, were named D3A5, B8G11, A9C8, which could stabilize the secretory anti RpfB domain MAb, which were D3A5, B8G11 as IgG1 subclass, A9C8 for IgM subclass, and its relative affinity was A9C8D3A5B8G11.
The pcDNA3.1 (-) -Rpf domain and the pcDNA3.1 (-) -RpfB domain eukaryotic expression vector were respectively constructed and transfected to COS-7 cells. The indirect immunofluorescence assay showed that the Rpf domain proteins and RpfB domain proteins were expressed in COS-7 cells, and the specificity of MAb was indirectly verified.
2.2 cross experiments against the Rpf domain and the anti RpfB domain MAb of the micrococcus aureus. Rpf, Rpf domain, RpfB domain, RpfA (the purified MTB RpfA protein in our laboratory, the plasmid is a foreign Mike Young Professor) and the two kinds of H37Ra as antigen and preparation, respectively. The results show that the two kinds of anti structural domains are all available. The above protein reacted with the H37Ra strain.
2.3 the recovery and growth of Micrococcus lutea Rpf, Rpf domain and RpfB domain protein to Micrococcus lutea and MTB H37Ra dormancy bacteria
After proper dilution of the dormant bacteria of Micrococcus Garcinia micrococcus and MTB H37Ra, they were randomly divided into 3 groups. Each group added the purified protein with different dilution concentration and the corresponding anti structural domain MAb to measure the OD600 value at different time points and draw the growth curve. The results showed that when the concentration of Rpf and Rpf in the Rpf and Rpf domains of the micrococcus Garcinia were 100pmol/L, the rattan was stimulated. The effect of Micrococcus aureus resuscitation and growth was obvious. When the concentration of Rpf was 10pmol/L and the concentration of Rpf domain was 100pmol/L, MTB H37Ra was stimulated to resuscitation and growth, and the stimulation was inhibited obviously after the MAb Rpf domain MAb was added to 1:600. When RpfB domain concentration was 1000pmol/L, the stimulus was stimulated. The effect of Micrococcus Luba Micrococcus resuscitation and growth was obvious. When the concentration of RpfB domain was 500pmol/L, the stimulation of MTB H37Ra resuscitation and growth was obvious, and the stimulation was obviously inhibited after 1:1000's RpfB domain MAb was added.
Immunological characteristics of Rpf, Rpf domain and RpfB domain of Micrococcus lutea 3.
Using the subcutaneous embedding method, Rpf, Rpf domain and RpfB domain protein were dripped to the micromass of the nitrocellulose membrane respectively. The mice were immunized for 3 times, each interval was 2 weeks, at the same time, the BCG immunization group and the normal saline control group were set up. The average titer of the specific antibody in the serum of the immune mice was detected by ELISA. The results showed: rattan yellow micro The titer of the highest antibody in the Rpf protein immunization group was 1:12800, the highest antibody titer of the Rpf domain protein immune group was 1:4800, and the highest antibody titer of the RpfB domain protein immune group was 1:6400..
In order to detect the cellular immune response caused by protein immunization in mice, the spleen lymphocytes of mice were separated after the last two weeks of immunization. The lymphocyte proliferation reaction was detected by MTT method after PPD stimulation in vitro. The stimulation index of Rpf, Rpf domain and RpfB domain protein in mice were 2.86 + 0.12,2 respectively. .10 + 0.09,2.40 + 0.11 was significantly higher than that in the normal saline control group (0.90 + 0.21) (P0.01), but less than the BCG immunization group (3.50 + 0.23) (P0.05). The average level of IFN- gamma, IL-10 and IL-12 induced by Rpf protein of Micrococcus Lutus Micrococcus were 1528 + 36ng/L, 485 + and 302 + 14ng. The average level of -12 was 1126 + 36ng/L, 368 + 13ng/L and 289 + 14ng/L, and IFN- gamma induced by RpfB domain protein, the average level of IL-10 and IL-12 was 1432 + 30ng/L, 503 + 11ng/L and 311 + 11ng/L, and 2022 +, 578 and 400 +, respectively, induced by BCG immunization group, respectively, and 578 + and 400 +. The levels of IFN- gamma, IL-10 and IL-12 were 256 + 6ng/L, 76 + 3ng/L and 56 + 4ng/L., respectively. The results showed that the level of cytokines induced by 3 protein immunization mice was significantly higher than that of normal saline control group (P0.01), but it was not as good as BCG immune group (P0.05).
In the fourth week after immunization, 105CFU MTB H37Rv strains were used to attack the mice in the above immunization groups and count the number of spleen bacterial loads. Compared with the normal saline control group, the Rpf, Rpf domain and RpfB domain protein immunization group had significant inhibitory effect on the proliferation of MTB in the spleen after the attack of H37Rv strain (the difference value). They were 1.89 log10,1.61 log10 and 1.78 log10) (P0.05), but not as BCG immunization group (2.83 log10) (P0.05).
Conclusion: the Rpf, Rpf domain and RpfB domain proteins of Micrococcus luberus all have the effect on promoting the recovery and growth of Micrococcus lubera and MTB dormant bacteria, which are expected to be used in the isolation and culture of clinical specimens, promote the recovery and growth of MTB dormant bacteria and improve the detection rate of the recessive infection, and the MAb of the two domains is not only obvious. The inhibition of the recovery and growth of the 3 proteins and the identification of a variety of Rpf proteins and their domains can be specifically identified. According to this, it is possible to establish a detection method for MTB related antigens; the specific immune responses induced by the 3 kinds of protein immunized animals have certain protective effects on the attack of MTB strains, and they may be used for the new epidemic of TB. The development of the seedlings.
【学位授予单位】:第四军医大学
【学位级别】:博士
【学位授予年份】:2008
【分类号】:R392
【相似文献】
相关期刊论文 前10条
1 汪圣强;王柯;裴豪;;主动外排系统与结核分枝杆菌耐药[J];中国医学工程;2011年07期
2 王海全;;64例尘肺结核痰结核分枝杆菌培养药敏结果分析[J];中国医药指南;2011年21期
3 董海燕;张建中;万康林;;结核分枝杆菌毒力相关因子研究进展[J];医学研究杂志;2011年06期
4 黄志强;张日东;吴智龙;陈世浩;;新型改良罗氏培养基与罗氏酸基检测结核分枝杆菌比较[J];广东医学;2011年09期
5 吕中全;张明新;张慧;;荧光定量聚合酶链反应检测结核分枝杆菌的价值[J];新乡医学院学报;2011年04期
6 陈士东;;296例结核性脑膜炎临床分析[J];医学理论与实践;2011年13期
7 金法祥;王华钧;孙小军;;DNA环介导恒温扩增试验检测结核分枝杆菌的研究[J];中华医院感染学杂志;2011年12期
8 廖传玉;黄正谷;陈天刚;李同心;万东勇;饶霞;徐艳;侯毅;钟敏;严哓峰;;2004~2009年我中心结核分枝杆菌临床株耐药趋势[J];临床肺科杂志;2011年08期
9 张伟铮;黄彬;林冬玲;鄂顺梅;薛新娜;曾建明;陈茶;;结核分枝杆菌自身淬灭探针荧光定量PCR检测方法的建立[J];中国热带医学;2011年06期
10 王瑞博;井申荣;;结核分枝杆菌分泌蛋白TB10.4的功能和应用[J];生命的化学;2011年04期
相关会议论文 前10条
1 戴广明;曹以诚;杜正平;陈洵;黄曙海;逄宇;周杨;黄海荣;赵雁林;;结核分枝杆菌环介导恒温扩增(LAMP)快速检测方法的构建[A];中华医学会结核病学分会2010年学术年会论文汇编[C];2010年
2 许优;孙惠平;张增贤;刘莉娜;;关于结核分枝杆菌定量方法的研究[A];中华医学会结核病学分会2006年学术会议论文汇编[C];2006年
3 刘毅;李卫民;田苗;孙照刚;李传友;周辉;张治国;高铁杰;高峰;;快速筛选定义北京基因型结核分枝杆菌的新方法[A];2007年中国防痨协会全国学术会议论文集[C];2007年
4 张月新;辛毅;马郁芳;;结核分枝杆菌RmlB的表达、纯化及酶促反应动力学研究[A];2008年全国糖生物学学术会议论文摘要[C];2008年
5 刘焰;刘胜武;谈蓉;马立新;刘君炎;;结核分枝杆菌Ag85B与ESAT-6双顺反子重组腺表达载体的构建[A];第六届全国免疫学学术大会论文集[C];2008年
6 吴园;钟敏;王易伟;钟静;胡频频;毛旭虎;;Rv0341用于诊断依赖利福平结核分枝杆菌结核病的研究概况[A];中国防痨协会临床委员会、中国防痨协会基础委员会学术研讨会论文集[C];2008年
7 张旭霞;张海青;李传友;田苗;赵冰;李卫民;张健源;印云青;焦扬;端木宏谨;;结核分枝杆菌黏附素HBHA防治结核病的动物实验研究[A];2005年中国防痨协会全国学术会议论文集[C];2005年
8 陈曦;张宗德;刘忠泉;贾红彦;邢爱英;古书香;;结核分枝杆菌rv3873、rv3879c基因原核表达载体的构建和表达[A];中华医学会结核病学分会2006年学术会议论文汇编[C];2006年
9 周庆;方中飞;沈小英;宋冰;方孝美;;临床分离结核分枝杆菌的耐药性分析[A];2006年浙江省检验医学学术年会论文汇编[C];2006年
10 陈涛;周琳;周杰;江勇;周志刚;彭建明;文力;彭东东;何超文;钟球;;环介导等温扩增法快速检测结核分枝杆菌的方法建立与临床应用评估[A];中华医学会结核病学分会2011年学术会议论文汇编[C];2011年
相关重要报纸文章 前10条
1 记者 韩晓玲 通讯员 范敬群 金安江;华中农大研究成果获世界声誉[N];湖北日报;2009年
2 庄愉;新型抗结核疫苗的开发研究[N];中国医药报;2002年
3 记者 陈青;让结核菌三天内原形毕露[N];文汇报;2009年
4 钱忠军;华中农大发现新基因有望控制结核病[N];江苏科技报;2009年
5 驻鄂记者 钱忠军 通讯员 金安江 范敬群;发现可能控制结核病的新基因[N];文汇报;2009年
6 记者 黄每裕;珠海推出两种检测试剂新产品[N];中国医药报;2009年
7 庄愉;新型抗结核疫苗的开发研究[N];中国医药报;2002年
8 记者 项铮;团山会议研讨罕见病原体防治策略[N];科技日报;2009年
9 ;整合力量 抗击“瘟神”[N];中国医药报;2003年
10 宋心德;IDSA2基因导致结核杆菌产生抗药性[N];医药经济报;2004年
相关博士学位论文 前10条
1 樊爱琳;Rpf蛋白结构域的生物学及免疫学特性的初步研究[D];第四军医大学;2008年
2 董海燕;中国13省市结核分枝杆菌基因多态性分析[D];中国疾病预防控制中心;2011年
3 陈嘉臻;结核分枝杆菌特异的RD2/RD11蛋白应用于结核免疫诊断的研究[D];复旦大学;2009年
4 王平;肺分枝杆菌感染临床特征、耐药模式、预后研究及肺组织结核分枝杆菌巢式PCR检测[D];北京协和医学院;2011年
5 陈军;武汉地区结核分枝杆菌药物敏感性及氟喹诺酮耐药分子机制的研究[D];华中科技大学;2011年
6 陈军;武汉地区结核分枝杆菌药物敏感性及氟喹诺酮耐药分子机制研究[D];华中科技大学;2011年
7 薛莹;结核分枝杆菌Rpf样蛋白生物学及免疫学活性的研究[D];第四军医大学;2005年
8 乐军;耐药结核分枝杆菌的多维分析[D];复旦大学;2003年
9 孙勇;北京地区结核分枝杆菌耐药分子特点及结核分枝杆菌耐喹诺酮类药物泵机制的初步研究[D];北京市结核病胸部肿瘤研究所;2012年
10 刘凯;结核分枝杆菌潜伏感染者和初发结核病患者免疫分子标识的筛选[D];北京协和医学院;2010年
相关硕士学位论文 前10条
1 李立青;结核分枝杆菌Rv2389c和Rv2450c基因的克隆表达及其生物学功能的初步研究[D];第四军医大学;2006年
2 高晓鹏;结核分枝杆菌Rv1884c和Rv0867c基因的克隆表达及其促生长作用的研究[D];第四军医大学;2007年
3 蔡溢;结核分枝杆菌RmlA的表达、纯化以及酶促反应动力学研究[D];大连医科大学;2006年
4 王霞芳;IFN-γ增强BALB/c小鼠对结核分枝杆菌感染的抵抗力[D];苏州大学;2002年
5 曹立雪;应用膜芯片检测结核分枝杆菌rpoB基因突变[D];中国人民解放军军事医学科学院;2003年
6 韩喜琴;噬菌体生物扩增法检测结核分枝杆菌药物敏感性研究及评价[D];北京市结核病胸部肿瘤研究所;2004年
7 王琳;结核分枝杆菌ClpX和ClpP2蛋白酶的克隆表达及其性质研究[D];西南大学;2010年
8 徐蕾;结核分枝杆菌三种复活促进因子的原核表达和初步应用[D];重庆医科大学;2007年
9 丁卫民;耐多药肺结核与结核分枝杆菌L型感染的临床研究[D];山西医科大学;2003年
10 吴玉敏;1.结核分枝杆菌去标签Mtb8.4-Hspx和Hspx-Mtb8.4基因克隆及表达 2.FTY720对肾移植受者治疗的安全性和有效性系统评价[D];兰州大学;2010年
,本文编号:2133720
本文链接:https://www.wllwen.com/yixuelunwen/shiyanyixue/2133720.html